Lv1
75 积分 2022-06-08 加入
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC
12天前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
1个月前
已完结
Vebreltinib: a promising milestone in targeted therapy for METex14-mutant NSCLC
3个月前
已完结
Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine
7个月前
已完结
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study
9个月前
已完结
Capmatinib inMETExon 14–Mutated orMET-Amplified Non–Small-Cell Lung Cancer
9个月前
已完结
Interstitial Pneumonitis Following Sequential Administration of Programmed Death-1/Programmed Death-Ligand1 Inhibitors and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors For Non-Small Cell Lung Cancer: A Matched-Pair Cohort Study Using a Nationwide Inpatient Database
10个月前
已完结
[Immune-related adverse events of immunocheckpoint inhibitors for lung cancer]
10个月前
已完结
Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
11个月前
已完结
皖公网安备34019202002308
